RBC Capital Remains Bullish on Viridian Therapeutics (VRDN) Following Q3 2025 Results

2 weeks ago 8

With important upside potential, Viridian Therapeutics, Inc. (NASDAQ:VRDN) secures a spot connected our database of the best small-cap biotech stocks to bargain according to analysts.

RBC Capital Remains Bullish connected  Viridian Therapeutics (VRDN) Following Q3 2025 Results

RBC Capital Remains Bullish connected Viridian Therapeutics (VRDN) Following Q3 2025 Results

On November 6, 2025, RBC Capital raised its terms people connected Viridian Therapeutics, Inc. (NASDAQ:VRDN) from $41 to $45, portion maintaining an “Outperform” rating. The concern firm’s bullish stance stemmed from wide visibility toward profitability, seen done its accrued currency presumption of $888 million, acknowledgment to financing deals, including $55 cardinal from DRI royalty financing, a $70 cardinal upfront Japan licensing agreement, a $289 cardinal follow-on offering, and entree to a $300 cardinal recognition facility.

Furthermore, Viridian Therapeutics, Inc. (NASDAQ:VRDN) has completed cardinal diligent enrollments successful its late-stage objective studies. Readouts for progressive and chronic Thyroid Eye Disease (TED) are expected successful Q1 and Q2 2026, respectively, driving the concern firm’s bullish stance.

Meanwhile, Viridian Therapeutics, Inc. (NASDAQ:VRDN) reported Q3 2025 results connected the erstwhile day. The institution closed the 4th with $490.9 cardinal successful currency connected hand. The currency presumption further accrued arsenic a effect of the financing deals. The 4th besides marked a important summation successful R&D expenses, which grew from $69.2 cardinal successful the aforesaid 4th past twelvemonth to $86.3 million.

Viridian Therapeutics, Inc. (NASDAQ:VRDN) is focused connected the improvement and commercialization of therapies for uncommon diseases.

While we admit the imaginable of VRDN arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 7 Best Oil and Gas Penny Stocks to Buy According to Analysts and Billionaire Jacob Rothschild’s RIT Capital Partners: 9 Stocks with Huge Upside Potential.

Disclosure: None.

Read Entire Article